Skip to content

Clinical trials

Completed Phase 1/2 Lung Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Phase 1/2 Status: Completed Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20131
20141
20172
20181
20191
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AVEO Pharmaceuticals, Inc.1
Adverum Biotechnologies, Inc.1
Aeris Therapeutics1
Beth Israel Deaconess Medical Center1
Grifols Therapeutics LLC1
Hoffmann-La Roche1
Navigation Sciences, Inc.1
Nordmark Arzneimittel GmbH & Co. KG1
R-Pharm1
Revolution Medicines, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases11
Respiratory Tract Diseases6
Lung Neoplasms4
Pulmonary Disease, Chronic Obstructive4
Carcinoma, Non-Small-Cell Lung3
Digestive System Diseases3
Emphysema3
Neoplasms3
Neoplasms by Site3
Respiratory Tract Neoplasms3

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.